Commitment to Patient Centricity and Diversity: Key ingredients for a successful trial November marks the start of Movember, an annual…

Omicron Presents New Challenges for Early Phase Trials The evolving coronavirus disease 2019 (COVID-19) pandemic continues to present challenges for…

How to report clinical trials affected by the COVID-19 pandemic: Dealing with extraordinary circumstances Since 2020, the COVID-19 pandemic has…

Learn how to reduce the impact of protocol amendments in clinical trials to improve efficiency, control costs and maintain study quality.

At Aixial Group, we deployed some immediate response measures like providing our holistic platform not for profit for COVID-19 trials and our ongoing business…

Radiopharmaceutical studies are not your average clinical trial.

Right now, a global movement to eliminate cervical cancer is being driven by the energy, passion and momentum…

Biotechnology’s Trusted Partner from Start to Finish Read more Aixial Group’s team of clinical experts can support your biotechnology company…

How Aixial Group applies 30+ years’ oncology trial experience to help find new therapies.